首页> 外文期刊>Journal of Inclusion Phenomena and Macrocyclic Chemistry >Inclusion complexes of fluconazole with β-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation
【24h】

Inclusion complexes of fluconazole with β-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation

机译:氟康唑与β-环糊精的包合物:理化性质及其制剂的体外评价

获取原文
获取原文并翻译 | 示例
           

摘要

Fluconazole (FZ) is a triazole antifungal drug administered orally or intravenously. It is employed for the treatment of mycotic infections. However, the efficacy of FZ is limited with its poor aqueous solubility and low dissolution rate. One of the important pharmaceutical advantages of cyclodextrins is to improve pharmacological efficacy of drugs due to increasing their aqueous solubility. The aim of present study was to prepare an inclusion complex of FZ and β-cyclodextrin (β-CD) to improve the physicochemical and biopharmaceutical properties of FZ. The effects of β-CD on the solubility of FZ were investigated according to the phase solubility technique. Complexes were prepared with 1:1 M ratio by different methods namely, freeze-drying, spray-drying, co-evaporation and kneading. For the characterization of FZ/β-CD complex, FZ amount, practical yield %, thermal, aqueous solubility, XRD, FT-IR and NMR (~1H and ~(13)C) analysis were performed. In vitro dissolution from hard cellulose capsules containing FZ/β-CD complexes was compared to pure FZ and its commercial capsules and evaluated by F1 (difference) and f2 (similarity) factors. Paddle method defined in USP 31 together with high pressure liquid chromatographic method were used in in vitro dissolution experiments. It was found that solubility enhancement by FZ/β-CD complexes depends on the type of the preparation method. High release of active agent from hard cellulose capsules prepared with β-CD complexes compared to commercial capsules was attributed to the interactions between β-CD and active agent, high energetic amorphous state and inclusion complex formation.
机译:氟康唑(FZ)是一种口服或静脉内给药的三唑类抗真菌药。它用于治疗霉菌感染。然而,FZ的功效因其水溶性差和溶解速率低而受到限制。环糊精的重要药学优势之一是由于其水溶性增加而提高了药物的药理效力。本研究的目的是制备FZ和β-环糊精(β-CD)的包合物,以改善FZ的理化和生物药学特性。根据相溶解度技术研究了β-CD对FZ溶解度的影响。通过不同方法,即冷冻干燥,喷雾干燥,共蒸发和捏合,以1:1 M的比例制备配合物。为了表征FZ /β-CD络合物,进行了FZ量,实际收率%,热,水溶性,XRD,FT-IR和NMR(〜1H和〜(13)C)分析。将含有FZ /β-CD复合物的硬质纤维素胶囊的体外溶出度与纯FZ及其市售胶囊进行比较,并通过F1(差异)和f2(相似性)因子进行评估。在体外溶出实验中使用了USP 31中定义的桨法和高压液相色谱法。发现通过FZ /β-CD复合物的溶解度提高取决于制备方法的类型。与市售胶囊相比,由β-CD络合物制备的硬质纤维素胶囊中活性剂的高释放归因于β-CD与活性剂之间的相互作用,高能非晶态和包合物形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号